Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A
- PMID: 12884344
- DOI: 10.1002/hed.10262
Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A
Abstract
Background: Gustatory sweating is a common complication of parotid surgery. Injection of botulinum toxin A has been reported as a safe and effective treatment option for patients with Frey's syndrome.
Patients and methods: A total of 69 patients who had undergone superficial parotidectomy because of adenoma were evaluated with respect to the incidence of Frey's syndrome and treatment interest. Minor's iodine starch test was used to detect the affected skin area. Affected skin areas were documented using a digital camera; skin areas were evaluated morphometrically. A single injection of Botox per 1 cm(2) skin field was administered to those patients interested in treatment.
Results: Of 43 patients (62%) with gustatory sweating, 33 patients requested treatment. The affected skin area varied from 16 cm(2) to 81 cm(2). The individual Botox dosage ranged from 16 to 80 IU. All relevant clinical symptoms of sweating disappeared within 1 week after a single injection. Treatment was well tolerated with no side effects.
Conclusion: Botox A injection is a safe and effective treatment with long-lasting effects for patients with extensive gustatory sweating.
Copyright 2003 Wiley Periodicals, Inc.
Similar articles
-
[Post-parotidectomy Frey's syndrome. Treatment with botulinum toxin type A].Acta Otorhinolaryngol Ital. 2000 Jun;20(3):187-91. Acta Otorhinolaryngol Ital. 2000. PMID: 11139877 Italian.
-
Treatment of Frey's syndrome with botulinum toxin.J Med Assoc Thai. 2007 Nov;90(11):2397-402. J Med Assoc Thai. 2007. PMID: 18181326
-
The use of botulinum toxin in Frey's Syndrome.Ir Med J. 2006 May;99(5):136-7. Ir Med J. 2006. PMID: 16892916
-
Management of Frey syndrome.Head Neck. 2007 Aug;29(8):773-8. doi: 10.1002/hed.20568. Head Neck. 2007. PMID: 17230557 Review.
-
Botulinum toxin for Frey's syndrome: a closer look at different treatment responses.J Laryngol Otol. 2012 Feb;126(2):185-9. doi: 10.1017/S0022215111002581. Epub 2011 Oct 3. J Laryngol Otol. 2012. PMID: 22018335 Review.
Cited by
-
Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force.Clin Exp Otorhinolaryngol. 2023 Nov;16(4):291-307. doi: 10.21053/ceo.2023.00458. Epub 2023 Oct 25. Clin Exp Otorhinolaryngol. 2023. PMID: 37905325 Free PMC article.
-
Botulinum Neurotoxins and Cancer-A Review of the Literature.Toxins (Basel). 2020 Jan 5;12(1):32. doi: 10.3390/toxins12010032. Toxins (Basel). 2020. PMID: 31948115 Free PMC article. Review.
-
Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.Toxins (Basel). 2013 Apr 23;5(4):821-40. doi: 10.3390/toxins5040821. Toxins (Basel). 2013. PMID: 23612753 Free PMC article. Review.
-
[Frey's syndrome of the external auditory canal].HNO. 2004 Oct;52(10):917-20. doi: 10.1007/s00106-003-1024-6. HNO. 2004. PMID: 15278226 German.
-
[On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].HNO. 2006 Nov;54(11):868-74. doi: 10.1007/s00106-006-1394-7. HNO. 2006. PMID: 16670876 German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical